Syndecan-1 inhibition promotes antitumor immune response and facilitates the efficacy of anti-PD1 checkpoint immunotherapy
Yun Liu(Renji Hospital), Yongzhong Liu(State Key Laboratory of Oncogene and Related Genes)
Cited by 14
Related Papers
Iron-dependent histone 3 lysine 9 demethylation controls B cell proliferation and humoral immune responses
|Nature Communications|2019|224
POH1 deubiquitylates and stabilizes E2F1 to promote tumour formation
|Nature Communications|2015|118
USP12 downregulation orchestrates a protumourigenic microenvironment and enhances lung tumour resistance to PD-1 blockade
|Nature Communications|2021|75
Transient mTOR Inhibition Facilitates Continuous Growth of Liver Tumors by Modulating the Maintenance of CD133+ Cell Populations
|PLoS ONE|2011|49
POH1 deubiquitinates pro-interleukin-1β and restricts inflammasome activity
|Nature Communications|2018|46